BA
AXSM icon

BlackRock Advisors’s Axsome Therapeutics AXSM Stock Holding History

BlackRock Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$26K Sell
3,783
-619
-14% -$4.35K ﹤0.01% 3399
2016
Q3 		$35K Buy
4,402
+1,558
+55% +$11.8K ﹤0.01% 3335
2016
Q2 		$21K Buy
+2,844
New +$26.2K ﹤0.01% 3432

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Advisors's AXSM Position: Q4 2016 in Review

BlackRock Advisors reduced its Axsome Therapeutics (AXSM) stake by 14% in Q4 2016, selling an estimated $4.35K and leaving 3,783 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

BlackRock Advisors first reported a position in AXSM in Q2 2016 and has held it in 3 quarters since. The position peaked at $35K in Q3 2016. 41 funds tracked by Wall St. Rank hold AXSM as of Q4 2016.

  • BlackRock Advisors held 3,783 shares of Axsome Therapeutics worth $26K as of Q4 2016.
  • BlackRock Advisors sold 619 Axsome Therapeutics shares in Q4 2016, an estimated $4.35K.
  • Axsome Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3399 holding.
  • BlackRock Advisors first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Advisors's Axsome Therapeutics position peaked at $35K in Q3 2016.
  • 41 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.